Relmada Therapeutics Inc (RLMD)
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026
Scholastic Corporation Announces Intent to Repurchase Up to $200 Million of its Common Stock Through Modified Dutch Auction Tender Offer
SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
FVCBankcorp Announces Extension of Share Repurchase Program
Origin Announces HP Embalagens as Strategic Distributor for Sustainable PET Bottlecaps
NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026
Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Toll Brothers Opens New Model Home at Regency at Ten Trails in Black Diamond, Washington